GS-441524 powder is a highly specialized form of an antiviral medication used to treat Feline Infectious Peritonitis (FIP), a serious and often fatal disease in cats caused by a mutation of the feline coronavirus. As an investigational drug, GS-441524 has shown considerable promise in clinical and practical settings for its ability to halt the progression of this previously untreatable disease.
Injectable Form: When reconstituted into an injectable solution, GS-441524 is typically administered subcutaneously. This route is particularly beneficial for cats with severe gastrointestinal symptoms, as it bypasses the digestive tract and ensures rapid systemic absorption.
Oral Suspension: Alternatively, the reconstituted powder can be given orally, either directly or mixed with food. This method is more convenient for long-term treatment, especially in a home care setting, and is often used for maintenance therapy after initial stabilization with injections.
Clinical studies and anecdotal evidence have demonstrated the efficacy of GS-441524 in treating various forms of FIP, including both the effusive (wet) and non-effusive (dry) forms. Many cats have shown significant improvement, with symptoms such as fever, weight loss, and lethargy resolving over time. In some cases, complete remission has been achieved, offering a new lease on life for cats that were once facing a grim prognosis.
| Property | Details |
|---|---|
| CAS Number | 1191237-69-0 |
| Grade | Pharmaceutcial Grade |
| Shipping Method | Air(UPS, FedEx, TNT, EMS) Or Sea |
| Density | 1.84±0.1 G |
| Appearance | White Powder |
| Storage | Store At Cool Dry Place |
| Molecular Weight | 291.26 |
| Purity |
99.0% |
GS-441524 powder is primarily used as a therapeutic agent for treating Feline Infectious Peritonitis (FIP), a severe and often fatal disease in cats caused by a feline coronavirus. This antiviral compound is a nucleoside analog that inhibits the replication of the virus by interfering with its RNA synthesis. It has shown remarkable efficacy in both experimental and practical settings for managing FIP. Key applications include:
1. FIP Treatment: Administered orally, via injection, or in tablet form, GS-441524 powder targets wet and dry forms of FIP, helping reduce symptoms such as fever, weight loss, abdominal effusion, and neurological issues.
2. Veterinary Use: Used by veterinarians and pet owners under guidance for compassionate use in cats diagnosed with FIP.
3. Research and Development: GS-441524 is also widely studied for its antiviral properties, contributing to the broader field of antiviral drug development.
